Risikoen for kardiotoksicitet er størst, når Herceptin anvendes i kombination med anthracykliner.
All candidates for treatment should undergo careful cardiac monitoring (see “ cardiotoxicity” section below). The risk of cardiotoxicity is greatest when Herceptin is used in combination with anthracyclines.